- Filed
- May 14, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2020 · May 1, 2020 | 39.15M sh |
| Cash And Equivalents | Q1 2020 · Mar 31, 2020 | $101.82M |
| Cash And Equivalents | Q1 2020 · Dec 31, 2019 | $103.21M |
| Stockholders Equity | Q1 2020 · Mar 31, 2020 | $102.01M |
| Stockholders Equity | Q1 2020 · Dec 31, 2019 | $168.5M |
| Total Liabilities | Q1 2020 · Mar 31, 2020 | $1.41B |
| Total Liabilities | Q1 2020 · Dec 31, 2019 | $1.57B |
| Total Assets | Q1 2020 · Mar 31, 2020 | $1.92B |
| Total Assets | Q1 2020 · Dec 31, 2019 | $2.14B |
| Cost Of Revenue | Q1 2020 · Mar 31, 2020 | $143.52M |
| Cost Of Revenue | Q1 2020 · Mar 31, 2019 | $149.96M |
| Stock Repurchased | Q1 2020 · Mar 31, 2019 | $20K |
| Dividends Paid | Q1 2020 · Mar 31, 2019 | $4.77M |
| Capex | Q1 2020 · Mar 31, 2019 | $14.2M |
| Operating Cash Flow | Q1 2020 · Mar 31, 2019 | $14.8M |
| Sga Expense | Q1 2020 · Mar 31, 2019 | $5.22M |
| Net Income | Q1 2020 · Mar 31, 2019 | −$32.33M |
| Operating Income restated | Q1 2020 · Mar 31, 2019 | −$7.84M |